Ontrak Net Income/Loss 2010-2024 | OTRK
Ontrak net income/loss from 2010 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
| Ontrak Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $-25 |
| 2023 | $-28 |
| 2022 | $-52 |
| 2021 | $-37 |
| 2020 | $-23 |
| 2019 | $-26 |
| 2018 | $-14 |
| 2017 | $-14 |
| 2016 | $-18 |
| 2015 | $-7 |
| 2014 | $-27 |
| 2013 | $-5 |
| 2012 | $-12 |
| 2011 | $-8 |
| 2010 | $-20 |
| 2009 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.007B | $0.011B |
| Ontrak, Inc. is an AI and telehealth enabled, virtualized outpatient healthcare treatment company. The company's Predict-Recommend-Engage(TM) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways. Ontrak, Inc., formerly known as Catasys Inc., is based in United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.885B | 19.59 |
| Encompass Health (EHC) | United States | $12.215B | 25.89 |
| DaVita (DVA) | United States | $10.944B | 15.39 |
| Chemed (CHE) | United States | $8.456B | 26.58 |
| Elanco Animal Health (ELAN) | United States | $6.566B | 14.06 |
| Option Care Health (OPCH) | United States | $5.418B | 24.15 |
| RadNet (RDNT) | United States | $4.551B | 288.86 |
| Amedisys (AMED) | United States | $3.089B | 20.78 |
| LifeStance Health (LFST) | United States | $2.271B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.044B | 22.44 |
| Astrana Health (ASTH) | United States | $1.505B | 37.29 |
| U.S Physical Therapy (USPH) | United States | $1.211B | 31.26 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.112B | 63.33 |
| Pennant (PNTG) | United States | $1.025B | 37.65 |
| Atai Life Sciences (ATAI) | Germany | $0.369B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |